{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:08:50Z","timestamp":1778180930035,"version":"3.51.4"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,7,31]]},"DOI":"10.18632\/aging.204852","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T22:34:48Z","timestamp":1688682888000},"page":"7324-7332","source":"Crossref","is-referenced-by-count":2,"title":["The Eph\/Ephrin system in primary bone tumor and bone cancer pain"],"prefix":"10.18632","volume":"15","author":[{"given":"Lujuan","family":"Wang","sequence":"first","affiliation":[{"name":"Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Pan","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.2825356","article-title":"A novel putative tyrosine kinase receptor encoded by the eph gene.","volume":"23","author":"Takaku","year":"1987","journal-title":"Science"},{"key":"2","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms22168412","article-title":"The Clinical Impact of the EPH\/Ephrin System in Cancer: Unwinding the Thread.","volume":"2","author":"Theocharis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"3","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.3390\/ijms23095171","article-title":"The EPH\/Ephrin System in Bone and Soft Tissue Sarcomas\u2019 Pathogenesis and Therapy: New Advancements and a Literature Review.","volume":"2","author":"Theocharis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0076-3","article-title":"Claudin 11 regulates bone homeostasis via bidirectional EphB4-EphrinB2 signaling.","volume":"5","author":"Kim","year":"2018","journal-title":"Exp Mol Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bone.2017.04.003","article-title":"Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.","volume":"10","author":"Yang","year":"2017","journal-title":"Bone"},{"key":"6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3892\/ijmm.2016.2457","article-title":"Bradykinin receptors and EphB2\/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice.","volume":"3","author":"Liu","year":"2016","journal-title":"Int J Mol Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neulet.2011.04.008","article-title":"Involvement of EphB1 receptor\/ephrinB1 ligand in bone cancer pain.","volume":"49","author":"Tan","year":"2011","journal-title":"Neurosci Lett"},{"key":"8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijd.12968","article-title":"The role of Eph receptors and Ephrins in the skin.","volume":"5","author":"Fear","year":"2016","journal-title":"Int J Dermatol"},{"key":"9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1158\/1541-7786.MCR-06-0321","article-title":"Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.","volume":"5","author":"Poulsen","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.bbrc.2018.06.140","article-title":"Ephrin-B3 binds both cell-associated and secreted proteoglycans.","volume":"50","author":"Aasheim","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"11","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.1073\/pnas.0801302105","article-title":"Heparan sulfate regulates ephrin-A3\/EphA receptor signaling.","volume":"10","author":"Yamaguchi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"12","doi-asserted-by":"publisher","first-page":"7390104","DOI":"10.1155\/2018\/7390104","article-title":"Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.","volume":"201","author":"Kandpal","year":"2018","journal-title":"Biomed Res Int"},{"key":"13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond.","volume":"1","author":"Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nrm1662","article-title":"Eph receptor signalling casts a wide net on cell behaviour.","volume":"6","author":"Pasquale","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-ephrin bidirectional signaling in physiology and disease.","volume":"13","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ceb.2010.08.005","article-title":"Ephrins and Eph receptors in stem cells and cancer.","volume":"2","author":"Fris\u00e9n","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.14670\/HH-23.1011","article-title":"EPH receptors in cancer.","volume":"2","author":"Arango","year":"2008","journal-title":"Histol Histopathol"},{"key":"18","doi-asserted-by":"publisher","first-page":"111031","DOI":"10.1016\/j.celrep.2022.111031","article-title":"EPH receptor tyrosine kinases phosphorylate the PAR-3 scaffold protein to modulate downstream signaling networks.","volume":"4","author":"Bisson","year":"2022","journal-title":"Cell Rep"},{"key":"19","doi-asserted-by":"publisher","first-page":"e132447","DOI":"10.1172\/jci.insight.132447","article-title":"EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling.","volume":"4","author":"Weaver","year":"2019","journal-title":"JCI Insight"},{"key":"20","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1242\/jcs.008607","article-title":"The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells.","volume":"12","author":"Sakai","year":"2007","journal-title":"J Cell Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1007\/s00018-018-2858-0","article-title":"Neuronal GAP-Porf-2 transduces EphB1 signaling to brake axon growth.","volume":"7","author":"Feng","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/cancers15030963","article-title":"Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives.","volume":"1","author":"Machali\u0144ski","year":"2023","journal-title":"Cancers (Basel)"},{"key":"23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.","volume":"4","author":"Matsuo","year":"2006","journal-title":"Cell Metab"},{"key":"24","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood-2009-01-201954","article-title":"The ephrinB2\/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.","volume":"11","author":"Yaccoby","year":"2009","journal-title":"Blood"},{"key":"25","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1182\/blood-2004-12-4940","article-title":"Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.","volume":"10","author":"Matsumoto","year":"2005","journal-title":"Blood"},{"key":"26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3816\/CLML.2011.n.006","article-title":"Copy number variations of EphA3 are associated with multiple types of hematologic malignancies.","volume":"1","author":"Zhang","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s13402-017-0338-4","article-title":"EphA3 targeting reducesadhesion and invasion andgrowth and angiogenesis of multiple myeloma cells.","volume":"4","author":"D\u2019Auria","year":"2017","journal-title":"Cell Oncol (Dordr)"},{"key":"28","doi-asserted-by":"publisher","first-page":"1010428317694298","DOI":"10.1177\/1010428317694298","article-title":"EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.","volume":"3","author":"Liu","year":"2017","journal-title":"Tumour Biol"},{"key":"29","doi-asserted-by":"publisher","first-page":"e23447","DOI":"10.1097\/MD.0000000000023447","article-title":"Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R\/CCND1.","volume":"10","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"30","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/bjc.2013.578","article-title":"Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.","volume":"10","author":"Helder","year":"2013","journal-title":"Br J Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1365-2559.2010.03713.x","article-title":"De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway.","volume":"5","author":"Sers","year":"2010","journal-title":"Histopathology"},{"key":"32","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s11095-017-2272-6","article-title":"EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.","volume":"3","author":"Helder","year":"2017","journal-title":"Pharm Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41417-020-00221-4","article-title":"Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours.","volume":"2","author":"Kramer","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/cancers12061519","article-title":"Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.","volume":"1","author":"Capozzi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"35","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1038\/onc.2017.170","article-title":"Targeting EphA2 impairs cell cycle progression and growth of basal-like\/triple-negative breast cancers.","volume":"3","author":"Brantley-Sieders","year":"2017","journal-title":"Oncogene"},{"key":"36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41419-018-1164-y","article-title":"EPH receptor A2 governs a feedback loop that activates Wnt\/\u03b2-catenin signaling in gastric cancer.","volume":"9","author":"Ma","year":"2018","journal-title":"Cell Death Dis"},{"key":"37","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3390\/cells10112893","article-title":"EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing\u2019s Sarcoma and Chondrosarcoma.","volume":"1","author":"Pignochino","year":"2021","journal-title":"Cells"},{"key":"38","doi-asserted-by":"publisher","first-page":"e0175553","DOI":"10.1371\/journal.pone.0175553","article-title":"MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.","volume":"1","author":"Ding","year":"2017","journal-title":"PLoS One"},{"key":"39","doi-asserted-by":"publisher","first-page":"e9161","DOI":"10.1590\/1414-431X20209161","article-title":"Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma.","volume":"5","author":"Xu","year":"2021","journal-title":"Braz J Med Biol Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/cncr.10749","article-title":"Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.","volume":"9","author":"Clayer","year":"2002","journal-title":"Cancer"},{"key":"41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-0463.2009.02448.x","article-title":"Immunohistochemical profile of ephrin A4 expression in human osteosarcoma.","volume":"11","author":"Abdallaha","year":"2009","journal-title":"APMIS"},{"key":"42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/0019-509X.58859","article-title":"Ephrin A4 expression in osteosarcoma, impact on prognosis, and patient outcome.","volume":"4","author":"Abdallaha","year":"2010","journal-title":"Indian J Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/cancers15010272","article-title":"Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma.","volume":"1","author":"Burdach","year":"2022","journal-title":"Cancers (Basel)"},{"key":"44","doi-asserted-by":"publisher","first-page":"e71449","DOI":"10.1371\/journal.pone.0071449","article-title":"EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1.","volume":"8","author":"Tirado","year":"2013","journal-title":"PLoS One"},{"key":"45","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.1158\/0008-5472.CAN-05-2468","article-title":"Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.","volume":"6","author":"Griffioen","year":"2005","journal-title":"Cancer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/ijc.31405","article-title":"EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.","volume":"14","author":"Tirado","year":"2018","journal-title":"Int J Cancer"},{"key":"47","doi-asserted-by":"publisher","first-page":"eabf9394","DOI":"10.1126\/sciadv.abf9394","article-title":"A live single-cell reporter assay links intratumor heterogeneity to metastatic proclivity in Ewing sarcoma.","volume":"7","author":"Renella","year":"2021","journal-title":"Sci Adv"},{"key":"48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/his.12275","article-title":"Molecular pathology of bone tumours: diagnostic implications.","volume":"6","author":"Mangham","year":"2014","journal-title":"Histopathology"},{"key":"49","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.humpath.2009.03.024","article-title":"Down-regulation of ephrin-A5, a gene product of normal cartilage, in chondrosarcoma.","volume":"4","author":"Roessner","year":"2009","journal-title":"Hum Pathol"},{"key":"50","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.3390\/ijms20236047","article-title":"Bone Pain in Cancer Patients: Mechanisms and Current Treatment.","volume":"2","author":"Wordliczek","year":"2019","journal-title":"Int J Mol Sci"},{"key":"51","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1158\/0008-5472.CAN-10-3870","article-title":"Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents.","volume":"7","author":"Song","year":"2011","journal-title":"Cancer Res"},{"key":"52","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.pain.2013.08.017","article-title":"EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord.","volume":"15","author":"Song","year":"2013","journal-title":"Pain"},{"key":"53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/01616412.2021.1884798","article-title":"Blockade of Spinal EphA4 Reduces Chronic Inflammatory Pain in Mice.","volume":"4","author":"Jiang","year":"2021","journal-title":"Neurol Res"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:51:47Z","timestamp":1691283107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,7,31]]}},"alternative-id":["204852","37413995"],"URL":"https:\/\/doi.org\/10.18632\/aging.204852","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}